Cover Image

A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.

An abstract of the research paper presented to the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, in partial requirement for the course DVT 5436 – Research Project Mast cell tumours (MCTs) are one of the common neoplasia reported in canine and feline species with unpredictable biolo...

Full description

Saved in:
Bibliographic Details
Main Author: Chan Xin Wen
Format: Undergraduate Final Project Report
Language:English
Published: 2022
Online Access:http://discol.umk.edu.my/id/eprint/10626/1/CHAN%20XIN%20WEN.pdf
http://discol.umk.edu.my/id/eprint/10626/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.umk.eprints.10626
record_format eprints
spelling my.umk.eprints.106262023-04-02T04:44:54Z http://discol.umk.edu.my/id/eprint/10626/ A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021. Chan Xin Wen An abstract of the research paper presented to the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, in partial requirement for the course DVT 5436 – Research Project Mast cell tumours (MCTs) are one of the common neoplasia reported in canine and feline species with unpredictable biological behaviour. This creates difficulty in selection of treatment protocols and greatly affecting the treatment outcomes. Therefore, this systematic review is conducted to reveal the knowledge gap to venture into new therapy, also to summarize the responses and outcomes of advanced therapy for mast cell tumours in canine and feline patients reported between the years 2010 to 2021. Thus, a total of 18,760 publications from 2010 to 2021 were extracted from two databases, Science Direct and PubMed using 24 sets of search phrases. A total of 33 studies have met the eligibility criteria after four sequential screenings according to inclusion and exclusion criteria. 97.0% of studies included discussed canine MCTs, whereas 3.0% discussed feline MCTs. Various new and modifications of therapies such combination therapeutic protocols and novel chemotherapeutics drugs such as Tigilanol Tiglate (TT) have been reviewed in this paper. All proposed and reported therapies appeared to be beneficial and efficient in managing mast cell tumours in canine and feline species. Keywords: Mast cell tumour, canine, feline, novel, therapy 2022-05 Undergraduate Final Project Report NonPeerReviewed text en http://discol.umk.edu.my/id/eprint/10626/1/CHAN%20XIN%20WEN.pdf Chan Xin Wen (2022) A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021. Final Year Project thesis, Universiti Malaysia Kelantan. (Submitted)
institution Universiti Malaysia Kelantan
building Perpustakaan Universiti Malaysia Kelantan
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaysia Kelantan
content_source UMK Institutional Repository
url_provider http://umkeprints.umk.edu.my/
language English
description An abstract of the research paper presented to the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, in partial requirement for the course DVT 5436 – Research Project Mast cell tumours (MCTs) are one of the common neoplasia reported in canine and feline species with unpredictable biological behaviour. This creates difficulty in selection of treatment protocols and greatly affecting the treatment outcomes. Therefore, this systematic review is conducted to reveal the knowledge gap to venture into new therapy, also to summarize the responses and outcomes of advanced therapy for mast cell tumours in canine and feline patients reported between the years 2010 to 2021. Thus, a total of 18,760 publications from 2010 to 2021 were extracted from two databases, Science Direct and PubMed using 24 sets of search phrases. A total of 33 studies have met the eligibility criteria after four sequential screenings according to inclusion and exclusion criteria. 97.0% of studies included discussed canine MCTs, whereas 3.0% discussed feline MCTs. Various new and modifications of therapies such combination therapeutic protocols and novel chemotherapeutics drugs such as Tigilanol Tiglate (TT) have been reviewed in this paper. All proposed and reported therapies appeared to be beneficial and efficient in managing mast cell tumours in canine and feline species. Keywords: Mast cell tumour, canine, feline, novel, therapy
format Undergraduate Final Project Report
author Chan Xin Wen
spellingShingle Chan Xin Wen
A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
author_facet Chan Xin Wen
author_sort Chan Xin Wen
title A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
title_short A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
title_full A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
title_fullStr A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
title_full_unstemmed A systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
title_sort systematic review: advances therapies in canine and feline mast cell tumours from 2010 to 2021.
publishDate 2022
url http://discol.umk.edu.my/id/eprint/10626/1/CHAN%20XIN%20WEN.pdf
http://discol.umk.edu.my/id/eprint/10626/
_version_ 1763304268172886016
score 13.211869

Similar Items